Boots Ultra Cold and Flu Relief All in One

Quick links to important sections

Boots Ultra Cold and Flu Relief All in One

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Boots Ultra Cold and Flu Relief All in One

Boots Ultra Cold and Flu Relief All in One is a proprietary, non-sedating multi-action combination drug designed for temporary, comprehensive symptomatic relief from the common cold and flu in adults and adolescents. As an Over-The-Counter (OTC) medication, it is supplied as an oral dosage form, typically a tablet or caplet, to provide accessible relief.

Property Description
Active Ingredients Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride
Form Oral Dosage Form (Tablet/Caplet)
Pharmacological Class Analgesic-Antipyretic, Expectorant, and Sympathomimetic Decongestant
Common Use Temporary relief of multi-symptoms associated with cold and flu
Origin Synthetic

Composition and Pharmacological Classification

The preparation is defined by its core active ingredients: Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride. This fixed-dose combination is clinically recognized for simultaneously addressing pain, fever, and congestion. The multi-ingredient formulation establishes its pharmacological class as a combination of a systemically acting pain reliever/fever reducer, a mucolytic agent, and a nasal decongestant. Acetaminophen is included for its analgesic and antipyretic properties, managing pain and reducing fever.

Purpose of the Multi-Action Drug Type

The fundamental purpose of this combination drug is the efficient mitigation of multiple cold and flu symptoms through a single administration. Guaifenesin functions as an expectorant, a class of mucoactive drugs that works by thinning respiratory mucus to ease clearance. Concurrently, Phenylephrine Hydrochloride is included as a sympathomimetic nasal decongestant, which aims to reduce swelling in the nasal passages. This streamlined approach delivers integrated multi-symptom relief, covering systemic discomfort, chest congestion, and nasal obstruction.

Regulatory References

  1. Source: DailyMed, National Library of Medicine
  2. Source: NIH Research on Guaifenesin

What side effects are possible with Boots Ultra Cold and Flu Relief All in One?

Possible Side Effects and Safety Information

Boots Ultra Cold and Flu Relief All in One contains a combination of active ingredients: paracetamol (an analgesic and antipyretic), phenylephrine hydrochloride (a decongestant), and caffeine (a mild stimulant).


General Safety Information

It is crucial not to exceed the stated dose as this can cause serious harm, particularly to the liver due to the paracetamol content. This product should not be taken with any other paracetamol-containing products or other flu, cold, or decongestant remedies. If symptoms persist for more than three days, a healthcare professional should be consulted.

Possible Side Effects

Like all medicines, this product can cause side effects, although not everybody gets them. The most common side effects are generally mild. Discontinue use and seek immediate medical attention if you experience signs of a severe allergic reaction (e.g., swelling of the face, mouth, or throat, difficulty breathing, rash) or serious skin reactions.

System/Class Common Side Effects (May affect up to 1 in 10 people) Rare Side Effects (May affect up to 1 in 1,000 people)
Gastrointestinal Nausea, vomiting.
Nervous System Headache, dizziness, difficulty sleeping (insomnia), restlessness (due to caffeine). Tremor.
Cardiovascular Increased heart rate (palpitations), increased blood pressure.
Blood/Skin Skin rash, itching, blood disorders (e.g., thrombocytopenia).

Note: Due to the phenylephrine component, individuals with pre-existing conditions such as heart disease, high blood pressure, thyroid problems, or diabetes should consult a doctor or pharmacist before use.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

This section details the officially documented overdose manifestations and mandatory help-seeking actions as established in government regulatory sources. Information is strictly limited to overdose warnings and does not include mechanisms, general safety, usage, or dosing.

Documented Overdose Manifestations

Overdose presentations are primarily linked to the acetaminophen and phenylephrine components.

Component Documented Manifestations
Acetaminophen Nausea, vomiting, stomach/abdominal pain, sweating, extreme tiredness, or later signs like jaundice (yellowing eyes/skin) and dark urine.
Phenylephrine Fast/irregular heartbeat (tachycardia, palpitations), severe headache due to high blood pressure, hallucinations, and seizures.

Required Emergency Actions and Severe Outcomes

Immediate medical attention is critical for all individuals in the event of a suspected overdose, even if no initial signs or symptoms are present. This is due to the potential for severe liver damage (hepatotoxicity) from the acetaminophen component, which can be delayed and potentially fatal. Severe outcomes also include life-threatening complications such as hypertensive crisis, cardiac events, and severe skin reactions (SJS/TEN).

You must seek immediate medical advice or contact a Poison Control Center right away.

Increased hazard of overdose and toxicity is documented for individuals with chronic alcohol abuse, pre-existing hepatic or renal impairment, and those with low body weight or malnutrition.

Therapeutic Uses of Boots Ultra Cold and Flu Relief All in One

The primary therapeutic purpose of Boots Ultra Cold and Flu Relief All in One may assist with supportive relief across key symptomatic domains for individuals experiencing the acute episodes of the common cold or influenza. This combination medication is applied in clinical settings that involve acute or disruptive symptom patterns, and is relevant for easing overall symptom load that creates noticeable physiological strain.

Multi-ingredient products with this active composition are commonly used to help with acute, concurrent symptoms including general aches and pains, headache, feverishness, nasal congestion, and productive chest cough. The primary therapeutic purpose is relevant for easing symptoms that may interfere with daily comfort.


Quick Fact: Supportive Management of Multiple Symptoms

This medication is generally applied in contexts that involve concurrent manifestations of systemic discomfort, respiratory congestion, and mucus production. This may contribute to improved comfort during periods of heightened symptoms.


Symptomatic Domains Covered

The product is used in situations involving certain distressing symptoms, providing core analgesic and antipyretic support for pain and fever, expectorant support for chest mucus, and decongestant support for the nasal passages. This may assist with maintaining a sense of stability when symptoms are more noticeable.

Regulatory References

  1. U.S. National Library of Medicine DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Boots Ultra Cold and Flu Relief All in One?

Population eligibility for this combination medicine (Paracetamol, Guaifenesin, and Phenylephrine Hydrochloride) is strictly defined by regulatory guidance concerning age and pre-existing medical conditions.

Age-Based Eligibility

Age Group Regulatory Status
Children (Under 16 years) Contraindicated/Prohibited
Adults and The Elderly Approved for use (16 years and over)

Contraindicated Populations (Must Not Use)

Use of this medication is strictly contraindicated for individuals with certain serious conditions, including a known allergy to any ingredient, a serious heart condition or cardiovascular disorder(s), high blood pressure (hypertension), glaucoma, an overactive thyroid, or phaeochromocytoma.

Use is also prohibited for patients currently taking Monoamine Oxidase Inhibitors (MAOI's) or having taken them within the last 14 days, and for those taking beta-blocking drugs or other decongestant drugs.

Conditional Use (Requires Consultation)

Eligibility is conditional for certain populations. Individuals with kidney or liver problems (including alcoholic liver disease), diabetes, circulatory disorders, or those who are pregnant or breast-feeding must consult a health professional prior to use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for products containing Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride documents several interaction-related constraints, classified primarily by the resulting severity and mechanism.

Interaction Classification
Contraindicated Combinations

The co-administration of this product is officially prohibited with several drug classes, primarily due to the risk of severe pharmacodynamic or toxic effects. This includes Monoamine Oxidase Inhibitors (MAOIs), Beta-blocking drugs, Tricyclic Antidepressants, and other Sympathomimetic Decongestant Drugs. Co-administration with any other medicine containing Acetaminophen is also prohibited to avoid exceeding the maximum daily dose.

Official Restrictions and Requirements
Timing Rule

A period of at least 14 days must elapse between stopping an MAOI and starting this medicine.

| Metabolic and Exposure Alterations |

Regulatory documents state that Barbiturates may increase the risk of liver damage due to accelerated Acetaminophen metabolism (enzyme induction). Conversely, Metoclopramide or Domperidone may increase the speed of Acetaminophen absorption, while Colestyramine may reduce its absorption. Regular, prolonged use of Acetaminophen may officially potentiate the effect of Warfarin and other anticoagulants.

| Substance Restrictions |

Co-administration with Alcohol is strictly prohibited in the official patient information due to the increased risk of severe liver damage (hepatotoxicity).

| Population-Specific Note |

The risk of metabolic acidosis when co-administered with Flucloxacillin is noted in regulatory documents as being heightened in patients with pre-existing conditions such as severe renal impairment, sepsis, malnutrition, or chronic alcoholism.

Mechanism of Action

How Boots Ultra Cold and Flu Relief All in One Works

This formulation's action is defined by the concurrent, independent mechanisms of its components, each targeting a distinct physiological system.

Central Modulation of Regulatory Systems

The paracetamol mechanism involves the central nervous system (CNS) where it modulates the synthesis of prostaglandin E2 ( PGE2) in the hypothalamus. This action influences the signaling sequence controlling the thermoregulatory set-point and affects nociceptive transmission. This domain influences pathways linked to the hypothalamic thermoregulatory center and nociceptive pathways.


Targeted Vasoconstriction in Autonomic Pathways

The decongestant mechanism involves the direct activation of alpha1-adrenergic receptors located on the vascular smooth muscle cells of the nasal mucosa. This direct agonism initiates a cascade that leads to localized vasoconstriction, which restricts blood flow in the mucosal tissues. This process affects blood volume and pressure in the mucosal vessels, resulting in reduced tissue fluid accumulation.


Enhancement of Respiratory Secretion Dynamics

The guaifenesin mechanism acts as a secretagogue, influencing mechanisms that increase the volume and hydration of respiratory secretions. This action is thought to be initiated by the stimulation of vagal afferent nerves via a gastro-pulmonary reflex. This mechanism modifies the rheology (viscosity) of the secretions, thereby supporting the function of mucociliary clearance.

Dosage and Administration Information

The use of Boots Ultra Cold and Flu Relief All in One is governed by strict, label-based regulatory instructions that define the standard approach to administration and dosing. This medication is exclusively for Oral administration in the form of capsules, tablets, or a powder for oral solution.

Standard Dosing and Frequency

Population Dose per Administration Minimum Dosing Interval Maximum Daily Dose
Adults and Older Adults 2 capsules/tablets OR 1 sachet 4 to 6 hours 8 capsules/tablets OR 4 sachets

The regimen for individuals 16 years and over involves taking the specified dose every 4 to 6 hours as required, ensuring at least four hours elapse between doses. This usage pattern is for short-term administration only, and the medicine should not be taken for longer than 3 days without consultation.

Administration Requirements

  • Capsules/Tablets: Swallow the units whole with water; they must not be chewed.
  • Powder for Oral Solution: The contents of the sachet must be fully dissolved in hot (but not boiling) water and cooled to a drinkable temperature before ingestion.

A fundamental constraint is the Acetaminophen Duplication Rule: The product contains acetaminophen, and no other medicine containing this ingredient may be taken concurrently. The total daily intake of acetaminophen from all sources must not exceed 4000 mg in 24 hours. Use is restricted to adolescents aged 12 or 16 years and over, depending on the specific formulation.

Recent Clinical Evidence

Boots Ultra Cold and Flu Relief All in One: Recent Clinical Evidence

The formulation of this product contains three active pharmaceutical ingredients: Paracetamol (an analgesic and antipyretic), Guaifenesin (an expectorant), and Phenylephrine (a decongestant). Research evidence for this combination focuses on the established roles of each component in symptomatic relief from cold and flu.


Component Research Focus

Active Ingredient Primary Symptom Area in Studies
Paracetamol Pain, Headache, and Fever
Phenylephrine Nasal Congestion and Sinusitis
Guaifenesin Viscosity and Clearance of Mucus

Evidence Overview of Combination Use

Studies involving multi-component fixed-dose combinations containing an analgesic (like paracetamol), a decongestant (like phenylephrine), and an expectorant (like guaifenesin) have examined the effect on overall cold symptom scores in adults.

Initial clinical research examined the measured change in the frequency of pain episodes and fever in participants compared to baseline. A key area of investigation has been whether the presence of the decongestant and expectorant components, in addition to the pain reliever, contributed to observed differences in symptom burden.

Regarding congestion, research examined measured scores related to nasal blockage and ease of breathing. Furthermore, studies on expectorants like guaifenesin evaluated the potential for changes in the viscosity and volume of mucus to promote easier clearance from the chest and throat, a key measure related to chesty coughs.

The final evidence from these various studies describes the measured outcomes in specific trial participants under controlled conditions, informing the combination's use for the temporary relief of multiple cold and flu symptoms.

Frequently Asked Questions (FAQ)

Common questions about Boots Ultra Cold and Flu Relief All in One (FAQ)


Q: How long does the relief from one dose of this medicine typically last?

Official administration instructions define the minimum interval between doses as 4 to 6 hours. This interval indicates the typical duration before another dose is required to maintain symptomatic relief. Patients are required to adhere strictly to the minimum time specified on the packaging between doses.


Q: Does this medicine cause drowsiness or make you sleepy?

The active ingredients in this formulation are generally not associated with causing drowsiness or sleepiness. However, official documents do list dizziness as a possible side effect. If dizziness occurs, official guidance states that the operation of machinery or driving should be avoided.


Q: Is it safe to drink alcohol while using this medicine, according to official guidance?

Official guidance strictly states that co-administration with alcohol is prohibited while taking this medicine. This is due to the increased risk of severe liver damage (hepatotoxicity) that is associated with the paracetamol component.


Q: What is the primary purpose of the cough ingredient in this formulation?

The cough ingredient, guaifenesin, is officially described as an expectorant. Its function is to help loosen or thin the mucus and phlegm in the chest, which is intended to make them easier to clear through coughing.


Q: Why do some people experience dry mouth when taking cold and flu medicines like this?

While dry mouth is not listed as a common side effect in all official documents, it is a known possible effect linked to medicines containing sympathomimetic decongestants like phenylephrine. The action of the decongestant component can sometimes affect certain bodily secretions.


Q: What does the official product document say about taking this during pregnancy?

Official regulatory guidance advises individuals who are pregnant or breast-feeding to consult a doctor or pharmacist prior to using this medicine. This consultation is generally required to assess suitability where risks are not fully established for these specific populations.


Q: Is there information on whether this medicine can affect driving ability?

Regulatory documents state that this medicine could cause side effects such as dizziness. If these effects occur, official guidance states that the operation of machinery or driving should be avoided.


Q: What is the general level of evidence supporting the use of the combined ingredients?

The use of this combination is supported by the established clinical efficacy of each active component (paracetamol, guaifenesin, and phenylephrine) in treating specific cold and flu symptoms. Research evidence focuses on these individual roles and the measured effects observed in studies of similar multi-component fixed-dose combinations.


Q: Can this product be used for symptoms of a chesty cough?

Yes, official product information indicates that this medicine is intended for the relief of symptoms including a chesty cough. This action is provided by the expectorant ingredient, guaifenesin, which helps to thin and clear mucus from the chest.


Q: Is Boots Ultra Cold and Flu Relief All in One the same as other 'all-in-one' cold medicines?

Not all 'all-in-one' cold medicines contain the exact same combination of active ingredients. This specific formulation is defined by its contents: paracetamol (for pain/fever), guaifenesin (for chesty cough), and phenylephrine hydrochloride (for congestion).


Q: Can Boots Ultra Cold and Flu Relief All in One be taken for a regular headache?

This medicine is officially authorized for the relief of multiple symptoms associated with colds and flu, which includes headache and fever. It is generally intended to be used only when a patient is experiencing the full range of symptoms it is designed to treat.


Q: Is it okay to take this medicine if I'm only experiencing a runny nose?

Official product instructions state that this medicine should only be used if a patient is experiencing all the target symptoms it is formulated to treat. Using it for a single symptom, such as a runny nose, is not consistent with the intended use described in the regulatory documents.


Q: What is the difference between this and Boots Cold & Flu Relief Tablets?

The key difference between specific product variants, such as other Boots Cold & Flu Relief Tablets, lies in their active ingredient profiles and concentrations. This 'Ultra' product contains the specific combination of paracetamol, guaifenesin, and phenylephrine hydrochloride.


Q: Are there common stomach side effects with Boots Ultra Cold and Flu Relief All in One?

Yes, official documents list gastrointestinal side effects such as nausea, vomiting, and stomach upsets as possible, although generally mild, side effects associated with the use of this medicine.


Q: What are the non-medical ingredients listed in Boots Ultra Cold and Flu Relief All in One?

The full list of non-medical ingredients (excipients) is detailed in the official patient information leaflet and Summary of Product Characteristics. These ingredients are included for the structure, stability, or appearance of the dosage form.


Q: Can I take this if I have kidney issues, as described in product information?

Official patient guidance specifies that individuals with kidney problems must consult a doctor or pharmacist before using this medicine. This is required to assess the suitability of the paracetamol component for those with pre-existing conditions.


Q: Is a slight increase in heart rate expected after taking this medicine?

Official documents list an increased heart rate (palpitations) as a possible side effect. This effect is linked to the presence of the decongestant component, phenylephrine.


Q: What should I do if I accidentally take two doses too close together?

If an accidental overdose is suspected, or if doses are taken too close together, medical attention should be sought at once. This caution is in place because taking too much paracetamol can cause serious, delayed liver damage, even if a person currently feels well.


Q: Are there any foods or drinks that should be avoided while using this product?

Official regulatory guidance strictly prohibits the consumption of alcohol while taking this product due to the risk of severe liver damage. No other specific food or drink is consistently prohibited in the documentation.


Q: Why is it described as an 'All in One' treatment?

The term 'All in One' reflects the product's official classification as a fixed-dose combination containing multiple active ingredients. It is intended to simultaneously treat the systemic discomfort, congestion, and chesty cough symptoms of cold and flu in a single medicine.


Q: Does the medicine contain ibuprofen?

No, the active ingredients listed in the official product information are paracetamol, guaifenesin, and phenylephrine hydrochloride. Ibuprofen is not listed as an active component in this specific formulation.


Q: Why do people sometimes say they feel sleepy after taking cold and flu medications?

This specific product is formulated with ingredients that are not generally sedating. However, other types of cold and flu medicines may contain older-generation antihistamines which can cause drowsiness, contributing to general user confusion about all cold medicines.


Q: What class of drug does the decongestant component belong to?

The decongestant component, phenylephrine, belongs to the class of drugs known as sympathomimetic agents. These agents work by stimulating receptors in the body that cause the blood vessels in the nasal passages to constrict.


Q: Is the evidence for this product based on studies on similar combinations or this exact one?

Research evidence for the use of this product is based on the established clinical efficacy of the individual components and studies conducted on fixed-dose combinations containing similar active ingredients. The evidence supports the product's function in multi-symptom relief.


Q: How does the official documentation describe the treatment of fever with this drug?

Official documentation describes the paracetamol component as an antipyretic, meaning it helps to reduce a person's temperature when they have a fever. It also functions as an analgesic, treating pain like headaches and body aches.


Q: Why is this medication not recommended for prolonged use?

Regulatory guidance specifies that this medicine should only be used for a short period (no longer than 3 days) without seeking medical advice. This limitation is primarily due to the risk of serious liver damage that is associated with prolonged use of the paracetamol component.

How should Boots Ultra Cold and Flu Relief All in One be stored and disposed of?

Storage and Disposal Requirements

The storage and handling of Boots Ultra Cold and Flu Relief All in One must comply strictly with the conditions defined in the official regulatory labeling to ensure product quality and child safety.

Official Storage Conditions

Requirement Type Labeled Constraint
Maximum Temperature Must not be stored above 25 C.
Stability Period Do not use the medicine after the expiry date printed on the carton and blister/sachet.
Child Safety Keep this medicine out of the sight and reach of children.

Disposal

The labeling does not provide specific instructions for household disposal of unused or expired product. Users are advised to dispose of the medicine according to local regulations or to consult a pharmacist for guidance on handling pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Boots Ultra Cold and Flu Relief All in One found in:

A-Z Index: